drugset / Trial / NCT01927263
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to investigate similarity between NI-071 and infliximab(the comparator) in terms of efficacy in patients with Rheumatoid Arthritis not adequately responding to Methotrexate.
Timeline
- Start
- 2013-07
- Primary completion
- 2015-03
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Infliximab | Monoclonal antibody | — | — |
| Subject | NI-071 | Unknown | — | — |